Daiichi says new API import ban will affect Ranbaxy's US ops
Daiichi-Sankyo says ensuring API supply could be a problem at Ranbaxy’s US finished product sites after imports are banned from yet another of its Indian facilities.
Archives for January 27, 2014
Par Pharmaceutical steps into sterile injectables with $490m JHP deal
Par Pharmaceutical Companies has agreed to buy JHP Group Holdings for $490M (€358M) to add sterile injectables to its offering.
Vive l’excipact: French Seppic excipients site gets certified
A French subsidiary of specialty ingredients firm Seppic has become the latest supplier certified under the Excipact quality scheme for drug excipients
Actavis to sell Foshan JV stake days after calling China 'too risky'
Actavis has announced plans to sell its stake in its Chinese subsidiary just days after telling investors the country is 'too risky' for new investments.